Electrochemical detection from Canatu

Electrochemical detection

Electrochemical detection using Canatu CNT offers the highest sensitivity outside a lab – over ten times more sensitive than anything our competitors can offer.

 


Exceptional sensitivity unlocks unprecedented electrochemical detection capabilities for new assays

Canatu CNT offers over 10x higher sensitivity compared to our competition. This superior sensitivity has been proven in in vitro matrices. It’s achieved through our patented dry deposition technology that allows us to produce CNTs with uniquely extensive and pristine reaction surfaces. Exceptional sensitivity unlocks unprecedented detection capabilities for new assays. Our proprietary click chemistry enables the detection of any analyte of interest, be it DNA mutations, pathogens, hormones or drug molecules, making it a versatile platform technology. Canatu has the expertise and experience to produce tens of millions of sensors every year.

Key benefits:

  • Sensitive: unprecedented detection capabilities for new assays
  • Versatile: click chemistry enables the detection of any analyte of interest
  • At scale: experience and expertise to produce tens of millions of sensors every year
Electrochemical detection using Canatu CNT offers superior signal to background ratio

Over 10x higher sensitivity

Canatu CNT offers the highest sensitivity outside a lab; over ten times more sensitive than anything our competitors can offer. Proven in in vitro matrices, this superior sensitivity enables unprecedented detection capabilities for new assays. It’s achieved through our patented dry deposition™ technology, which allows us to produce carbon nanotubes with uniquely large and pristine reaction surfaces.

Canatu carbon nanotubes click chemistry DNA

Versatile platform technology

Our proprietary click chemistry enables the immobilization of any biorecognition element, including antibodies, DNAs, enzymes, and aptamers, making it a versatile platform technology for detecting any analyte of interest. This offers an unprecedented opportunity to detect severe diseases and infections at their earliest stages. Canatu has, for example, demonstrated pre-metastatic cancer detection by analyzing circulating tumor DNA from small blood samples at the point of care.

Lab on a chip

Lab on a chip

Multiple biomarkers can be tested simultaneously from a single sample at ultra-low concentrations, including DNA mutations, pathogens, hormones, and drug molecules. These microfluidic chips offer high sensitivity, portability, and the ability to perform complex analyses with minimal sample consumption.

Download technical data

We are looking to partner with frontrunners ready to transform medical diagnostics at the point of care. Download technical data to explore our capabilities further.

See products

Electrochemical sensors for point of use diagnostics from Canatu
Electrochemical biosensors

Medical diagnostics is about to be transformed – saving lives and money. Canatu’s electrochemical biosensors offer the highest sensitivity outside a lab – over ten times more sensitive than anything our competitors can offer. Exceptional sensitivity unlocks unprecedented opportunity to detect new assays, as well as severe diseases and infections, at their earliest stages.

DISCOVER THE PRODUCT
Electrochemical sensors based on Canatu carbon nanotubes for environmental monitoring
Electrochemical sensors

Electrochemical sensors offer unparalleled detection capabilities across industries. Their superior sensitivity allows detection of substances at extremely low concentrations, making them indispensable for on-site monitoring of critical parameters in medical diagnostics, veterinary care, environmental monitoring, food & beverages, and industrial processes. Discover our future developments.

DISCOVER THE PRODUCT
Electrochemical detection for electrochemical biosensors, environmental monitoring, veterinary, and more.

Electrochemical detection using Canatu CNT

Electrochemical detection using Canatu CNT offers over 10-fold increased sensitivity in in vitro matrices. This exceptional sensitivity is made possible by our patented dry deposition technology, which allows us to create CNTs with uniquely pristine and extensive surface areas. To put it into perspective, a mere gram of Canatu CNTs has the surface area equivalent to that of a soccer field! This enormous, three-dimensional surface area provides many binding sites for biorecognition elements that interact with the target analyte. Consequently, this enables stronger signal and more sensitive measurement of specific chemical analytes, even in complex matrices. This exceptional sensitivity unlocks unprecedented electrochemical detection capabilities for new assays.

The superior sensitivity is achieved through our patented dry deposition™ technology that allows us to produce CNTs with uniquely pristine and extensive surfaces, providing many binding sites for the biorecognition elements that interact with the target analyte.

Our proprietary click chemistry provides a versatile platform technology for detecting any analyte of interest, be it DNA mutations, pathogens, hormones, or drug molecules. This presents an unseen opportunity to detect severe diseases and infections in their earliest stages. Click chemistry utilizes biorecognition elements, such as DNAs, antibodies, aptamers and enzymes to modify electrodes for specific target analytes. These elements interact with the target analyte, generating electrical signals that are then processed by an electronic system.

The unique structure of CNTs provides distinct advantages for electrochemical detection. Their three-dimensional carbon structure allows for sturdy and reliable attachment of biorecognition elements, enabling effective functionalization across a diverse range of applications.

Canatu has the expertise and experience to produce tens of millions of sensors every year.

Canatu has the expertise and experience to produce tens of millions of sensors every year. Moreover, we excel in customizing our CNTs to meet specific application requirements. We can tune both individual CNTs and the overall CNT network morphology to suit particular needs. For example, bundle size can be adjusted during CNT synthesis to optimize click chemistry, and carbon nanotubes can undergo purification to remove residual iron from the synthesis process. Our extensive in-house post-processing capabilities extend to surface functionalization, allowing for the immobilization of biorecognition elements to achieve selectivity for specific target analytes. Both our dry deposition and electrode patterning processes are fully compatible with roll-to-roll production and have been successfully demonstrated at industrial scale.




Contact Ilkka on electrochemical detection

Send us a message

We are looking for a partner for product development and commercialization. If you’re interested in exploring this opportunity further, contact our CTO Ilkka Varjos.

Related content

Medical diagnostics using electrochemical biosensors from Canatu
Electrochemical detection research

While our experts solve the issues of today, they are also working on what’s to come. Currently, our technology for electrochemical sensors is developing fast. Because of the exceptional purity of Canatu CNTs, remarkable analytical performance can be attained in various sectors such as clinical analysis, environmental monitoring, agriculture and neuroscience. Learn more. 

medical diagnostics
Advancing medical diagnostics

Simple and inexpensive lab-level tests will give caregivers better means to determine the best patient care at the point-of-care. Learn our role in advancing medical diagnostics.

Electrochemical sensors for point of use diagnostics from Canatu
Electrochemical biosensors

The inherently large surface area, high conductivity and tailorable surface chemistry makes Canatu CNTs an ideal electrode material for electrochemical biosensors. See the product.

Canatu electrochemical sensor strip
Clinical studies

Electrochemical sensors for bedside blood concentration measurement progress to clinical studies. The new point-of-use measurement enables real-time detection of analgesics from blood without extensive sample treatment, improving test result wait time, cost and convenience. See press release. 

Biosensors for medical diagnostics from Canatu
Hybrid sensor

Finnish ecosystem spurs diagnostics development. Canatu will develop a new hybrid electrochemical sensor for target detection and drug concentration measurement. See press release.

Partnering for better tomorrows

Canatu partners with forerunner companies, research partners and a leading Finnish University Hospital, together transforming products for better tomorrows with nano carbon. See how we collaborate for an impact.